Wellington Management Reports 11.5 Percent Stake in Celera | GenomeWeb
NEW YORK (GenomeWeb News) – Boston-based investment advisor Wellington Management Company owns an 11.53 percent stake in Celera, according to a US Securities and Exchange Commission filing today.
 
According to the 13G/A filing, Wellington, in its capacity as an investment advisor, owns 9,094,951 shares on behalf of clients of the firm. It noted in the filing that “no such client is known to have such right of power with respect to more than five percent” of Celera’s common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.